The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.

PRIORITY PRESS - American Transplant Congress 2010

Improving Long-term Outcomes in Kidney Transplant Recipients

San Diego, California / May 1-5, 2010

San Diego - The calcineurin inhibitors (CNIs) have long been the anchor of transplant immunosuppression, leading to low acute rejection rates in the short term. However, short-term gains have had little impact on long-term graft survival,...

PRIORITY PRESS - American Transplant Congress 2009

Preserving Organ Function with Non-CNI-Based Immunosuppressive Regimens

Boston, Massachusetts / May 30-June 3, 2009

Boston - Recognizing that calcineurin inhibitors (CNIs) may be nephrotoxic and/or diabetogenic, immunosuppressive protocols that minimize exposure to CNIs have gained acceptance in a variety of transplantation settings. Studies discussed...

PRIORITY PRESS - American Transplant Congress 2009

Outcomes in Kidney Transplant Recipients: Focus on Diabetes and BK-associated Nephropathy

Boston, Massachusetts / May 30-June 3, 2009

Boston - Short-term equivalency has been demonstrated for calcineurin inhibitors (CNIs) in widespread use today for prevention or treatment of graft rejection. Differences begin to emerge as outcomes are assessed over the longer term,...

MEDICAL FRONTIERS - World Congress of Nephrology

Improving Phosphate Control in Patients with Chronic Kidney Disease

Milan, Italy / May 22-26, 2009

Milan - Serum phosphorus has emerged as a pivotal player in the pathophysiology of skeletal and vascular manifestations of chronic kidney disease (CKD), with sobering mortality rates among both dialysis and pre-dialysis patients....

PHYSICIAN PERSPECTIVE Viewpoint based on the following article: J Am Soc Nephrol 2009;20(4):893-900.

Advances in Renoprotection and Cardiovascular Outcomes

April 2009

INTRODUCTION Uncontrolled high blood pressure (BP) contributes to deterioration of renal function, and optimizing BP is the primary means to reduce renal failure. However, large-scale clinical trials have demonstrated that...

MEDICAL OPTIONS in Chronic Kidney Disease

Issues in Phosphate Binder Therapy: Addressing the Needs of Hemodialysis Patients - Reviews from published literature

Chronic Kidney Disease-Mineral Bone Disorder: The Kidney Disease Improving Global Outcomes Initiative Dr. David Mendelssohn, University of Toronto, Ontario Exploring the Rationale Behind the Need for Non-calcium-Containing Phosphate...

ABSTRACTS in PERSPECTIVE based on presentations from the American Transplant Congress 2008

Preserving Renal Function: Exploring Calcineurin Inhibitor-sparing Regimens in Renal Allograft Recipients

May 30-June 4, 2008 / Toronto, Ontario

EDITORIAL OVERVIEW R. Jean Shapiro, MD, ABIM, FRCPC Medical Director, Renal Transplantation Medical Manager, Solid Organ Transplantation Vancouver General Hospital Clinical Associate Professor of Medicine University of British...

45th Annual Congress of the European Renal Association (ERA)/European Dialysis and Transplant Association (EDTA)

Chronic Kidney Disease: New Strategies to Reduce Phosphate Burden

Stockholm, Sweden / May 10-13, 2008

Stockholm - Disorders of mineral metabolism are linked to cardiovascular (CV) morbidity and mortality in patients with chronic kidney disease (CKD) who are on dialysis. Above all, hyperphosphatemia is associated with the development of CV...

National Kidney Foundation 2008 Spring Clinical Meetings

Managing Serum Phosphate in Chronic Kidney Disease

Dallas, Texas / April 2-6, 2008

Dallas - Virtually all patients with chronic kidney disease (CKD) have disturbed mineral metabolism that worsens with CKD progression. Among potential disturbances in mineral metabolism, elevated serum phosphorus poses a significant risk of...

MEDICAL OPTIONS Cardiovascular Risk Factors

The Kidney-Heart-Brain Axis: Update on RAS Inhibition

February 2008

The Essence of RAS Inhibition in Hypertension Dr. Lyall Higginson, Royal Jubilee Hospital The Renin-angiotensin System in Diabetes Dr. Sheldon Tobe, University of Toronto Maximizing Nephroprotection: The Role of RAS Inhibition Dr. Paul René...

PAGE 3 OF 6   1 2 3 4 5 6